Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pulsed Electromagnetic Field Treatment With Dementia Patients

NCT: NCT06862557 · RECRUITING

NCT IDNCT06862557
StatusRECRUITING
Start Date2025-04-01
Completion2027-09-30
SponsorHerrick Medical LLC (INDUSTRY)
First posted
Last updated

Brief Summary

An open label pilot study in mild to moderate AD/ADRD patients to assess the effects of treatment with ECHS AD/ADRD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end point is the The Alzheimer's Disease Assessment Scale-Cognitive Subscale. Participants will be followed-up for 9 months post-treatment.

Frequently Asked Questions

What is Pulsed Electromagnetic Field Treatment With Dementia Patients?

Pulsed Electromagnetic Field Treatment With Dementia Patients is a clinical trial registered under NCT06862557. Current status: RECRUITING.

What is the status of NCT06862557?

The current status of NCT06862557 (Pulsed Electromagnetic Field Treatment With Dementia Patients) is: RECRUITING.

When did Pulsed Electromagnetic Field Treatment With Dementia Patients start?

Pulsed Electromagnetic Field Treatment With Dementia Patients started on 2025-04-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.